Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.

Clinical trial NCT02569879 · COMPLETED

Trial details

NCT number: NCT02569879
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Diphtheria Acellular Pertussis Tetanus Aspergillosis, Allergic Bronchopulmonary Diphtheria-Tetanus-acellular Pertussis Vaccines

Start date: 2015-10-01
Primary completion: 2018-04-14
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.